𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The evolution of primary chemotherapy in breast cancer treatment

✍ Scribed by Tadashi Ikeda; Hiromitsu Jinno; Masaki Kitajima

Publisher
Springer Japan
Year
2004
Tongue
English
Weight
749 KB
Volume
11
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Future prospects of neoadjuvant chemothe
Future prospects of neoadjuvant chemotherapy in treatment of primary breast cancer
✍ Hwei-Chung Wang; Su-Shun Lo πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 689 KB

Neoadjuvant chemotherapy in breast cancer was developed in the 1970s and is now used in patients with locally advanced or early resectable breast cancer. Early administration of systemic chemotherapy before local treatment in locally advanced breast cancer and early resectable breast cancer is inten

Chemotherapy in the treatment strategy o
Chemotherapy in the treatment strategy of breast cancer
✍ Dr. Paul P. Carbone πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 433 KB πŸ‘ 2 views

Although breast cancer presents as localized disease and is treated with local modalities, i.e. surgery and radiotherapy, patients die with metastatic disease. For patients with positive nodes, the recurrence rates are well known. It is this group of patients who should receive more aggressive trea

Combination chemotherapy in the treatmen
Combination chemotherapy in the treatment of advanced breast cancer
✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.